Evaluación de efectividad y seguridad comparativas del mesna para la prevención de cistitis hemorrágica, en pacientes con cáncer sometidos a quimioterapia con oxazofosfamidas

Díaz Ortega, Miguel Hernando; Fuentes Pachón, Juan Camilo; Peña Torres, Esperanza; Vanegas Escamilla, Egdda Patricia; Suárez, Amaranto; Rosales Oliveros, Carmen; López, Hugo Enrique; Méndez, Yolima.
Bogotá; IETS; mayo 2016. 52 p. tab, ilus.
Monografía en Español | BRISA, LILACS | ID: biblio-847222

Documentos relacionados

  1. Excellent Tolerability of Ifosfamide and Mesna Via Continuous Infusion in a Pediatric Patient Population.
  2. Cysteine-lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose-finding study.
  3. Mesna, an unusual agent causing hypersensitivity reactions during chemotherapy.
  4. Evaluation of the Efficacy of <i>Lactobacillus acidophilus</i> in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats.
  5. Evaluation of the stability profile of anticancer drugs: A review of Ifosfamide and Mesna regimen for the treatment of metastatic soft tissue sarcoma.
  6. Mesna-induced photodistributed dermatosis.
  7. The control of hyperhomocysteinemia through thiol exchange mechanisms by mesna.
  8. A retrospective study of treatment and prophylaxis of ifosfamide-induced hemorrhagic cystitis in pediatric and adolescent and young adult (AYA) patients with solid tumors.
  9. [8] and [10]-Gingerol reduces urothelial damage in ifosfamide-induced hemorrhagic cystitis via JAK/STAT/FOXO signaling pathway via IL-10.
  10. Long-term Effects of Intravenous Cyclophosphamide in Combination with Mesna Provided Intravenously and via Bladder Perfusion in a Patient with Severe Multifocal Motor Neuropathy.